As a key part of the John A. Moran Eye Center’s vision that “no person with a blinding condition should be without hope, understanding, and treatment,” we invest heavily in basic and translational research. Moran has more than 60 PhD researchers addressing a number of conditions including glaucoma, age-related macular degeneration, Stargardt disease, optic neuritis, retinal stroke, idiopathic intracranial hypertension, Usher syndrome, and retinopathy of prematurity. The Moran Eye Center has ranked as high as seventh in the nation for National Institutes of Health funding.
Key Research Initiatives
Our key research initiatives at the Moran Eye Center include the following:
Moran is home to the Intermountain Ocular Research Center a nonprofit, independent laboratory that performs basic, in-depth scientific research on intraocular lenses. In addition, the Center provides services and education to surgeons, clinical ophthalmologists, their patients, and intraocular lens manufacturers worldwide.
The Sharon Eccles Steele Center for Translational Medicine was established in 2009 to more quickly and cost-effectively turn scientific discoveries into clinically effective diagnostics and therapies for blinding eye conditions, and is currently focused on finding a better treatment for age-related macular degeneration. The SCTM is directed by Gregory S. Hageman, PhD.